v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from Operating activities:      
Net loss $ (39,135) $ (43,727) $ (30,189)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 3,465 2,073 2,006
Capitalized software impairment   3,956  
Allowance for credit losses 587 2,055 390
Inventory impairment 388 626 1,905
Share-based compensation 6,848 5,602 7,319
Non-cash interest expense 824 771 634
Loss on extinguishment of debt   4,427  
Loss on disposal of property and equipment 72 28  
Changes in certain assets and liabilities:      
Accounts receivable, net 3,541 (3,727) (8,831)
Inventory (395) 3,150 (1,098)
Net investments in sales-type leases (31) 997 1,193
Prepaid commission expense 958 (1,096) (1,319)
Prepaid expenses and other assets 4,674 (1,155) (2,845)
Accounts payable (1,750) (1,985) 2,029
Accrued expenses (502) (2,083) (2,243)
Other liabilities 257 (66)  
Deferred revenue (175) (843) (989)
Net Cash used in Operating activities (20,374) (30,997) (32,038)
Cash flows from Investing activities:      
Purchases of property and equipment and capitalized software (801) (1,466) (2,369)
Cash paid for acquisition, net of cash and restricted cash acquired   (2,553)  
Repayment of notes receivable   1,606 1,047
Net Cash used in Investing activities (801) (2,413) (1,322)
Cash flows from Financing activities:      
Payments of debt issuance costs (168) (2,624) (1,104)
Proceeds from issuance of long-term debt 10,000 57,479 25,000
Repayment of promissory note (211)    
Repayment of deferred and contingent consideration (500)    
Proceeds from issuance of warrants   2,521  
Repayment of long-term debt   (60,000) (1,200)
Payment for debt extinguishment cost   (4,185)  
Distribution to non-controlling interest (94)    
Proceeds from exercises of stock options 13 1 1
Net Cash provided by (used in) Financing activities 35,850 (6,808) 22,697
Net increase (decrease) in Cash, Cash equivalents and Restricted cash 14,675 (40,218) (10,663)
Cash, Cash equivalents and Restricted cash, Beginning of Period 19,459 59,677 70,340
Cash, Cash equivalents and Restricted cash, End of Period 34,134 19,459 59,677
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:      
Cash and cash equivalents 28,134 18,459 59,677
Restricted cash and cash equivalents 6,000 1,000  
Total cash, cash equivalents and restricted cash 34,134 19,459 59,677
Supplemental disclosure of cash flow information:      
Cash paid for interest 7,591 6,513 4,790
Transfer of inventory to property and equipment 106 92 210
Supplemental disclosure of non-cash investing and financing activities:      
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses 83 13 239
Reduction of accounts receivable in current and long-term notes receivable   $ 606 $ 6,468
Secondary public offering      
Cash flows from Financing activities:      
Proceeds from the issuance of common stock 20,700    
Payments of common stock offering issuance costs (1,731)    
ATM Program.      
Cash flows from Financing activities:      
Proceeds from the issuance of common stock 8,313    
Payments of common stock offering issuance costs $ (472)